Drugs / Treg/Tcon adoptive immunotherapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07552649 | Apr 2026 → Apr 2028 expected | acute myeloid leukemia | Antonio Pierini | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Treg/Tcon adoptive immunotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07552649 ↗ |
| Modality | Cell therapy | “Treg/Tcon adoptive immunotherapy in allogeneic cell transplantation” NCT07552649 ↗ |